Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (177)	2/25/2000 1:11:00 PM
From: Jim Oravetz	Read Replies (2) of 370

A group including Elliott Associates L.P. reduced its stake in Vion Pharmaceuticals Inc. (VION) to 14.8%. In a filing Tuesday with the Securities and Exchange Commission, the group said it sold 103,700 common shares between Feb. 15 and Feb. 22 at prices ranging from $14.54 and $16.05 a share, and currently holds 1.49 million shares of the New Haven, Conn., biopharmaceutical company Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next